CDE Detailed Report
Disease: general-data-protection-regulation-gdpr
Sub-Domain: Safety Data
CRF:
Sub-Domain: Safety Data
CRF:
| CDE ID | CDE Name | Variable Name | Definition | Short Description | Additional Notes (Question Text) | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guideline) | Sub Domain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | Source | Form Set | Form | Field | Domain | CDASH Variable | CDASH Definition | CDASH Label | Controlled Terminology | Prompt | Essentiality | Question Text | CDASH imp guidance | SDTM IG target | csDSR | PhenX | Data Type | CRF Completion Inst | SDTMIG Target Var | SDTMIG Target Map | Codelist Name | PVs | Pre Pop Value | Query Display | List Style |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C57964 | Laboratory procedure percent neutrophils value | LabProcedurePrctNeutrophilsVal | Value of percent neutrophils. | Value of percent neutrophils. | The latest Complete Blood Count Neutrophils % | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2018-01-22 11:03:02.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60535 | Gene editing off target interrogation bioinformatic type | GnEdOffTgtInterrgntBioinfoTyp | Type of bioinformatic method employed in interrogating off-target gene-editing results. | Type of bioinformatic method employed in interrogating off-target gene-editing results. | Off Target Interrogation: Bioinformatic | CRISPOR;CRISTA;Other (list) | CRISPOR;CRISTA;Other (list) | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:50:01.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Multiple Pre-Defined Values Selected |
|||||||||||||||||||||||||||||||
| C60471 | Abnormal hematopoeisis related to caused by genetic manipulation indicator | AbHmtpsRltToCsByGenManipInd | Indicator of whether abnormal hematopoeisis is related to or probably caused by genetic manipulation | Indicator of whether abnormal hematopoeisis is related to or probably caused by genetic manipulation | Is it related or likely due to the genetic manipulation? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 11:47:42.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60567 | Neurologic disorder preexist new incidence exacerbation follow drug product infusion describe text | NrDsPrxNwInExFlwDrPrInfDscTxt | Text describing exacerbation or new incidence of a pre-existing neurological disorder following drug product infusion. | Text describing exacerbation or new incidence of a pre-existing neurological disorder following drug product infusion. | Since drug product infusion has there been new incidence or exacerbation of a pre-existing neurologic disorder? If yes, describe: | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 15:02:28.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 255 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60503 | Vector copy number specimen type evidence gene modified hematopoiesis value | VCNSpcmnTypGnModHmtpsVal | Value of the vector copy number (VCN) for the selected specimen type displaying evidence of polyclonal gene-modified hematopoiesis | Value of the vector copy number (VCN) for the selected specimen type displaying evidence of polyclonal gene-modified hematopoiesis | VCN | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 14:32:32.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60514 | Gene modified hematopoiesis best characterize type | GenModHemtopoisBstCharTyp | Type of condition that best characterizes the observed gene-modified hematopoiesis. | Type of condition that best characterizes the observed gene-modified hematopoiesis. | Based on VCN and VISA, what best describes the gene-modified hematopoiesis? | Clonal dominance;Oligoclonal hematopoiesis;MDS;Leukemia/lymphoma | Clonal dominance;Oligoclonal hematopoiesis;Myelodysplastic syndrome (MDS);Leukemia/lymphoma | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 10:54:46.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60450 | Premalignant malignant hematopoiesis evidence dysplastic cell indicator | PreMlgnHmtpsEvdDysCelInd | Indicator of the presence of dysplastic cells evidencing premalignant or malignant hematopoiesis. | Indicator of the presence of dysplastic cells evidencing premalignant or malignant hematopoiesis. | Is there evidence of Premalignant/Malignant Hematopoiesis? Dysplastic Cells | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 09:19:39.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60546 | Gene editing site translocation on off target cytogenetic detection indicator | GnEdStTrnslocOnOfTgtCytoDetINd | Indicator of whether gene editing translocations between on-target and off-target sites were detected by cytogenetics. | Indicator of whether gene editing translocations between on-target and off-target sites were detected by cytogenetics. | Translocations between on-target and off-target editing sites detected by: Cytogenetics | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 13:10:07.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60482 | Integrating viral vector blood CD3 depleted indicator | IntgrtVrlVctrBldCD3DpltInd | Indicator of whether the integrating viral vector copy number (VCN) of blood is depleted of CD3. | Indicator of whether the integrating viral vector copy number (VCN) of blood is depleted of CD3. | CD3 depleted? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 13:21:58.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60525 | Gene editing blood CD19 plus lineage on target indel count | GnEdBldCD19PlsLinOnTgtIndelCt | Count of gene-editing on-target indels in the blood CD19+ lineage. | Count of gene-editing on-target indels in the blood CD19+ lineage. | On-target Indels in Specific Blood Lineages: CD19+ | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:20:12.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60461 | Cytogenetic abnormality type | CytogeneticAbnormalityTyp | Type(s) of cytogenic abnormalities identified in cytogenetics testing. | Type(s) of cytogenic abnormalities identified in cytogenetics testing. | Mark all that apply | Monosomy-13;Monosomy-20;Monosomy-5;Monosomy-7;Monosomy-Y;Trisomy+19;Trisomy+8;Translocation t(1:3);Translocation t(11,16);Translocation t(2,11);Translocation t(3,21);Translocation t(3,3);Translocation t(6,9);Deletion: del(12p)/12p-;Deletion: del(13q)/13q-;Deletion: del(20q)/20q-;Deletion: del(9q)/9q-;Deletion: del(11q)/11q-;Deletion: del(3q)/3q-;Deletion: del(5q)/5q-;Deletion: del(7q)/7q-;Inversion (3);Other i17q;Other abnormality (specify) | Monosomy-13;Monosomy-20;Monosomy-5;Monosomy-7;Monosomy-Y;Trisomy+19;Trisomy+8;Translocation t(1:3);Translocation t(11,16);Translocation t(2,11);Translocation t(3,21);Translocation t(3,3);Translocation t(6,9);Deletion: del(12p)/12p-;Deletion: del(13q)/13q-;Deletion: del(20q)/20q-;Deletion: del(9q)/9q-;Deletion: del(11q)/11q-;Deletion: del(3q)/3q-;Deletion: del(5q)/5q-;Deletion: del(7q)/7q-;Inversion (3);Other i17q;Other abnormality (specify) | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 09:51:37.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Multiple Pre-Defined Values Selected |
|||||||||||||||||||||||||||||||
| C60557 | Oncogene panel follow genotoxic event detection indicator | OncgnPnlFlwGntxcEvntDtctnInd | Indicator of whether an oncogene panel was performed following detection of a genotoxic event. | Indicator of whether an oncogene panel was performed following detection of a genotoxic event. | If genotoxic event detected was an Oncogene panel used? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 14:35:44.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60493 | Bone marrow mononuclear cell positive for integrating viral vector percent value | BMMCPostvFrIntgrtVrlVctrPctVal | Value of the percentage of bone marrow mononuclear cells (BMMC) positive for the integrating viral vector. | Value of the percentage of bone marrow mononuclear cells (BMMC) positive for the integrating viral vector. | Percentage of Bone Marrow Cells Positive for Integrating Vector: BMMC | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 13:33:03.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
0 | 100 | percent | ||||||||||||||||||||||||||||||
| C57965 | Laboratory procedure percent lymphocytes value | LabProcedurePrctLymphocytesVal | Value of percent lymphocytes. | Value of percent lymphocytes. | The latest Complete Blood Count Lymphocytes % | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2018-01-22 11:03:02.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60536 | Gene editing off target interrogation bioinformatic type other text | GnEdOffTgtInterrtBioinfoTypOTH | The free-text field related to "Gene editing off target interrogation bioinformatic type", specifying other text. | The free-text field related to "Gene editing off target interrogation bioinformatic type", specifying other text. | Off Target Interrogation: Bioinformatic: Other (list) | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:50:01.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 4000 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60472 | Abnormal hematopoeisis relationship genetic manipulation type | AbnmlHmtpsRltnshpGntcMnipTyp | Type of relationship believed to exist between observed abnormal hematopoiesis and performance of genetic manipulation. | Type of relationship believed to exist between observed abnormal hematopoiesis and performance of genetic manipulation. | Specify relationship | Unrelated;Definitely related;Probably related;Possibly related | Unrelated;Definitely related;Probably related;Possibly related | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 11:50:16.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60568 | Rheumatologic autoimmune prior disorder new instance exacerbation follow drug product infusion indicator | RhAiPrDsNwInExFlwDrPrInfInd | Indicator of whether a prior rheumatologic or other autoimmune disorder presented exacerbation or a new instance following drug product infusion. | Indicator of whether a prior rheumatologic or other autoimmune disorder presented exacerbation or a new instance following drug product infusion. | Since drug product infusion has there been new incidence or exacerbation of a prior rheumatologic or other autoimmune disorder | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 15:02:28.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60504 | Oligoclonal gene modified hematopoiesis evidence indicator | OligoclnlGnModHmtpsEvdncInd | Indicator of whether there is evidence of oligoclonal gene modified hematopoiesis. | Indicator of whether there is evidence of oligoclonal gene modified hematopoiesis. | Is there evidence of oligoclonal gene modified hematopoiesis? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 14:34:33.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60515 | Gene edit frequency text | GeneEditFrequencyTxt | Text field for capturing the frequency with which gene editing was performed. | Text field for capturing the frequency with which gene editing was performed. | Gene editing frequency performed: | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:03:20.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 25 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60451 | Dysplastic cell lineage name | DysplasticCellLineName | Name of the dysplastic cell lineage | Name of the dysplastic cell lineage | Lineages affected | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 09:23:14.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 100 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60547 | Gene editing site translocation on off target cytogenetic detection other text | GnEdStTnslcOnOfTgtCytDetOTH | The free-text field related to "Gene editing site translocation on off target cytogenetic detection indicator" specifying other text. | The free-text field related to "Gene editing site translocation on off target cytogenetic detection indicator" specifying other text. | Translocations between on-target and off-target editing sites detected by: Cytogenetics: Summarize | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 13:15:40.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 4000 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60483 | Integrating viral vector copy number blood CD3 plus lineage value | IntgrtVrlVCNBldCD3PlusLneagVal | Value of the integrating viral vector copy number (VCN) in blood for the CD3+ lineage | Value of the integrating viral vector copy number (VCN) in blood for the CD3+ lineage | VCN in Specific Lineages: CD3+ | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 13:25:18.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60526 | Gene editing blood CD15 plus lineage on target indel count | GnEdBldCD15PlsLinOnTgtIndelCt | Count of gene-editing on-target indels in the blood CD15+ lineage. | Count of gene-editing on-target indels in the blood CD15+ lineage. | On-target Indels in Specific Blood Lineages: CD15+ | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:20:12.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60462 | Cytogenetic abnormality type other text | CytogeneticAbnormalityTypOTH | The free-text field related to "Cytogenetic abnormality type", specifying other text. | The free-text field related to "Cytogenetic abnormality type", specifying other text. | Other abnormality (specify) | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 10:13:49.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 4000 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60558 | Whole exome sequencing follow genotoxic event detection indicator | WhlExmSqncFlwGntxcEvntDtctnInd | Indicator of whether whole exome sequencing was performed following detection of a genotoxic event. | Indicator of whether whole exome sequencing was performed following detection of a genotoxic event. | If genotoxic event detected was whole exome sequencing used? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 14:37:50.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60494 | Bone marrow CD34 plus cell positive for integrating viral vector percent value | BMCD34PlCPstvFrIntVrlVctPctVal | Value of the percentage of bone marrow CD34+ cells positive for the integrating viral vector. | Value of the percentage of bone marrow CD34+ cells positive for the integrating viral vector. | Percentage of Bone Marrow Cells Positive for Integrating Vector: CD34+ | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 13:33:03.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
0 | 100 | percent | ||||||||||||||||||||||||||||||
| C58800 | Death date | DeathDate | Date on which the subject/participant died | Date on which the subject/participant died | Date expired: | Date or Date & Time | Adult;Pediatric | Supplemental | 1.00 | 2018-12-12 12:24:18.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
BMTCTN | 1507A Release 5.10 | Follow Up Status Form - 1507 (F23) | F23DTHDT | |||||||||||||||||||||||||||||
| C60537 | Gene editing off target site screen count | GnEdOffTgtSiteScreenCt | Count of off-target gene editing sites screened. | Count of off-target gene editing sites screened. | Number of off-target editing sites screened | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:57:22.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60473 | Bone marrow aspirate perform indicator | BonMarowAspiratPerfrmInd | Indicator of whether any bone marrow aspiration was performed. | Indicator of whether any bone marrow aspiration was performed. | Bone Marrow Aspirate Performed? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 12:00:51.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60569 | Rheumatologic autoimmune prior disorder new incidence exacerbation follow drug product infusion describe text | RhAiPrDsNwInExFlwDrPrInfDscTxt | Text describing exacerbation or a new incidence of a prior rheumatologic or other autoimmune disorder following drug product infusion. | Text describing exacerbation or a new incidence of a prior rheumatologic or other autoimmune disorder following drug product infusion. | Since drug product infusion has there been new incidence or exacerbation of a prior rheumatologic or other autoimmune disorder? If yes, describe: | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 15:02:28.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 255 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60505 | Cell clone integrant comprise 20 percent clone population indicator | CelClnIntgCmpr20PctClnPopInd | Indicator of whether any cell clone(s) or integrant(s) comprise >=20 percent of all clones. | Indicator of whether any cell clone(s) or integrant(s) comprise >=20 percent of all clones. | Is there evidence of Clonal Dominance? i.e., Do any cell clone(s) or integrant(s) account for >=20% of all clones? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 14:36:37.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60516 | Gene edited hematopoietic stem progenitor cells blood CD3 depleted indicator | GenEditHSPCBldCD3DpltInd | Indicator of whether the gene-edited hematopoietic stem and progenitor cells (HSPC) blood is depleted of CD3. | Indicator of whether the gene-edited hematopoietic stem and progenitor cells (HSPC) blood is depleted of CD3. | CD3 depleted? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 13:21:58.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60452 | Premalignant malignant hematopoiesis evidence blast indicator | PreMlgnHmtpsEvdBlastInd | Indicator of the presence of blasts evidencing premalignant or malignant hematopoiesis. | Indicator of the presence of blasts evidencing premalignant or malignant hematopoiesis. | Is there evidence of Premalignant/Malignant Hematopoiesis? Blasts | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 09:19:39.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60548 | Gene editing site translocation on off target droplet digital polymerase chain reaction detection indicator | GnEdStTrOnOfTgDpDgPCRDtInd | Indicator of whether gene editing translocations between on-target and off-target sites were detected by droplet digital polymerase chain reaction (PCR). | Indicator of whether gene editing translocations between on-target and off-target sites were detected by droplet digital polymerase chain reaction (PCR). | Translocations between on-target and off-target editing sites detected by: Droplet Digital PCR | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 13:18:53.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60484 | Integrating viral vector copy number blood CD19 plus lineage value | IntgrtVrlVCNBldCD19PlsLneagVal | Value of the integrating viral vector copy number (VCN) in blood for the CD19+ lineage | Value of the integrating viral vector copy number (VCN) in blood for the CD19+ lineage | VCN in Specific Lineages: CD19+ | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 13:25:18.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60527 | Gene editing blood GPA plus lineage on target indel count | GnEdBldGPAPlsLinOnTgtIndelCt | Count of gene-editing on-target indels in the blood GPA+ lineage. | Count of gene-editing on-target indels in the blood GPA+ lineage. | On-target Indels in Specific Blood Lineages: GPA+ | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:20:12.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60463 | Genetic mutational panel indicator | GeneticMutationalPanelInd | Indicator of whether a genetic mutational panel was performed. | Indicator of whether a genetic mutational panel was performed. | Was a genetic mutational panel performed? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 10:16:11.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60559 | Whole genome sequencing follow genotoxic event detection indicator | WhlGnmSqncFlwGntxcEvntDtctnInd | Indicator of whether whole genome sequencing was performed following detection of a genotoxic event. | Indicator of whether whole genome sequencing was performed following detection of a genotoxic event. | If genotoxic event detected was whole genome sequencing used? | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 14:37:50.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60495 | Bone marrow colony forming cell positive for integrating viral vector percent value | BMCFCPstvFrIntVrlVctPctVal | Value of the percentage of bone marrow colony forming cells (CFC) positive for the integrating viral vector. | Value of the percentage of bone marrow colony forming cells (CFC) positive for the integrating viral vector. | Percentage of Bone Marrow Cells Positive for Integrating Vector: CFC | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 13:33:03.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
0 | 100 | percent | ||||||||||||||||||||||||||||||
| C59958 | White blood cell count | WhiteBloodCellCt | Count of white blood cells (WBC) in the subject/participant's complete blood cell (CBC) sample. | Count of white blood cells (WBC) in the subject/participant's complete blood cell (CBC) sample. | The latest Complete Blood Count WBC | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2020-09-01 13:36:15.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
CIBMTR | n/a | Form 2031 revision 2 | 10. WBC: | |||||||||||||||||||||||||||||
| C60538 | Gene editing off target site confirm count | GnEdOffTgtSiteConfirmCt | Count of off-target gene editing sites confirmed. | Count of off-target gene editing sites confirmed. | Number of off-target editing sites confirmed: | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:57:22.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60474 | Bone marrow aspirate result type | BonMarowAspiratResultTyp | Type(s) of results obtained from bone marrow aspiration. | Type(s) of results obtained from bone marrow aspiration. | Bone Marrow Aspirate Performed? | Abnormal cytogenetics;Normal cytogenetics;Dysplastic morphology;Malignant morphology;Normal morphology | Abnormal cytogenetics;Normal cytogenetics;Dysplastic morphology;Malignant morphology;Normal morphology | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 12:02:30.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Multiple Pre-Defined Values Selected |
|||||||||||||||||||||||||||||||
| C60570 | Hematologic disorder new incidence follow drug product infusion indicator | HmDsNwInFlwDrPrInfInd | Indicator of whether there was a new incidence of hematologic disorder following drug product infusion. | Indicator of whether there was a new incidence of hematologic disorder following drug product infusion. | Since drug product infusion has there been new incidence of a hematologic disorder. | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 15:02:28.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
| C60506 | Clone integrant minimum 20 percent representation integration site gene location | ClnIntgrMn20PctRpIntgrtStGnLoc | Location of the integration site (gene or flanking gene) of clone(s) or integrant(s) having >=20 percent representation in the clone population. | Location of the integration site (gene or flanking gene) of clone(s) or integrant(s) having >=20 percent representation in the clone population. | List the site of integration of dominant (>=20% representation) clone(s) [e.g. gene location or flanking gene location] | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 14:42:22.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 25 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60517 | Gene edited hematopoietic stem progenitor cells blood CD3 depleted conversion percent value | GenEdHSPCBldCD3DepltCnvPctVal | Value of the percentage of conversions related to CD3 depletion in gene-edited hematopoietic stem and progenitor cells (HSPC) in blood. | Value of the percentage of conversions related to CD3 depletion in gene-edited hematopoietic stem and progenitor cells (HSPC) in blood. | Percent Conversion | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:09:53.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
0 | 100 | percent | ||||||||||||||||||||||||||||||
| C60453 | Blast bone marrow type | BlastBoneMarrowTyp | Type of blast(s) present in bone marrow aspirate/biopsy. | Type of blast(s) present in bone marrow aspirate/biopsy. | Blasts type | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 09:28:44.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 255 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60549 | Gene editing site translocation on off target droplet digital polymerase chain reaction detection limit text | GnEdStTrOnOfTgDrDgPCRDtLmTxt | Text field for capturing the droplet digital polymerase chain reaction (PCR) detection limit for translocations of on target and off target gene editing sites. | Text field for capturing the droplet digital polymerase chain reaction (PCR) detection limit for translocations of on target and off target gene editing sites. | Translocations between on-target and off-target editing sites detected by: Droplet Digital PCR: If no, what is the limit of detection: | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 13:24:46.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities | 50 |
Free-Form Entry |
||||||||||||||||||||||||||||||||
| C60485 | Integrating viral vector copy number blood CD15 plus lineage value | IntgrtVrlVCNBldCD15PlsLneagVal | Value of the integrating viral vector copy number (VCN) in blood for the CD15+ lineage | Value of the integrating viral vector copy number (VCN) in blood for the CD15+ lineage | VCN in Specific Lineages: CD15+ | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 13:25:18.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60528 | Gene editing blood CD14 plus lineage on target indel count | GnEdBldCD14PlsLinOnTgtIndelCt | Count of gene-editing on-target indels in the blood CD14+ lineage. | Count of gene-editing on-target indels in the blood CD14+ lineage. | On-target Indels in Specific Blood Lineages: CD14+ | Numeric Values | Adult;Pediatric | Supplemental | 1.00 | 2021-04-23 11:20:12.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
| C60464 | Abnormal hematopoiesis best descriptor type | AbnormHematopoieBstDscrpTyp | Type of descriptor that best characterizes the abnormal hematopoiesis identified. | Type of descriptor that best characterizes the abnormal hematopoiesis identified. | What best describes the abnormal hematopoiesis? | MDS;Leukemia/lymphoma | Myelodysplastic syndrome;Leukemia/lymphoma | Alphanumeric | Adult;Pediatric | Supplemental | 1.00 | 2021-04-22 10:17:46.0 | Genotoxicity | Safety Data | Adverse Events/Toxicities |
Single Pre-Defined Value Selected |